A pay to impede an abortion pill that is commonly used in the US to end pregnancy was rejected by the US Supreme Court on Thursday.
The jury, in a majority opinion, said the anti- pregnancy groups and physicians challenging the medicine, mifepristone, lacked the constitutional standing to bring the case.
Abortion rights are one of the most pressing problems in the November elections, and Democrat Party President Joe Biden had pleaded with the court to keep exposure to the medicine, which was approved by the FDA in 2000. Donald Trump, his Democratic opponent, is largely in favor of preventing pregnancy entry.
The conservative-dominated Supreme Court heard the first major abortion case since it overturned the legal right to abortion two years ago, in the mifepristone case. ” We recognise that some citizens, including the claimant doctors below, have genuine concerns about and objections to others using mifepristone and obtaining abortions”, said Justice Brett Kavanaugh, who wrote the 9- 0 mind. However, Kavanaugh claimed that” people and physicians do not have standing to file a lawsuit simply because individuals are permitted to engage in certain activities.”
The conservative justice claimed that the federal courts were” the wrong forum for addressing the plaintiffs ‘ concerns about FDA’s actions” and that they could raise objections through legislative processes or “political and electoral processes.” Pregnancy opponents have been campaigning to restrict access to the pill’s use across the country, claiming it is illegal and that anti-abortion doctors were being forced to stoop in on their consciences by intervening on patients who experienced problems after using it.
Medication abortion accounted for 63 % of the abortions in the country last year, up from 53 % in 2020, according to the Guttmacher Institute.
Since the Supreme Court overturned the landmark Roe v. Wade decision, which for the first half a century had enshrined the legal right to abortion, in June 2022, some 20 claims have prohibited or restricted pregnancy. AP
